IndraLab

Statements


JOSD1 affects Neoplasms
| 1 5
JOSD1 inhibits Neoplasms.
| 3
| 3

reach
"Additionally, JOSD1 suppression inhibited the tumor growth and improved chemosensitivity in vivo."

reach
"Furthermore, we found the high expression of Ki67 in JOSD1-depleted xenografts, indicating that JOSD1 could accelerate tumor proliferation in HNSCC."

reach
"In our study, JOSD1 knockdown could inhibit the growth and colony formation of TSCCA and SCC25 cells, and suppress the tumor growth in vivo."
JOSD1 activates Neoplasms.
| 1 2
| 1 2

eidos
"Furthermore , we found the high expression of Ki67 in JOSD1-depleted xenografts , indicating that JOSD1 could accelerate tumor proliferation in HNSCC ."

reach
"Knockdown of JOSD1 attenuates tumor growth and improves chemosensitivity of HNSCC cells in vivo."

reach
"Furthermore, we found the high expression of Ki67 in JOSD1-depleted xenografts, indicating that JOSD1 could accelerate tumor proliferation in HNSCC."
JOSD1 affects SOCS1
1 1 | 2 1
JOSD1 binds SOCS1.
1 | 1 1
1 | 1 1

sparser
"JOSD1 physically interacts with SOCS1, which is an essential negative regulator of many cytokines signaling, and enhances SOCS1 stability by deubiquitinating K48-linked polyubiquitination of SOCS1."

No evidence text available

reach
"JOSD1 physically interacts with SOCS1, which is an essential negative regulator of many cytokines signaling, and enhances SOCS1 stability by deubiquitinating K48 linked polyubiquitination of SOCS1."
JOSD1 ubiquitinates SOCS1.
| 1
JOSD1 leads to the ubiquitination of SOCS1. 1 / 1
| 1

reach
"JOSD1 Negatively Regulates Type-I Interferon Antiviral Activity by Deubiquitinating and Stabilizing SOCS1."
JOSD1 deubiquitinates SOCS1.
1 |
JOSD1 deubiquitinates SOCS1. 1 / 1
1 |

"JOSD1 Negatively Regulates Type-I Interferon Antiviral Activity by Deubiquitinating and Stabilizing SOCS1"
BRD4 affects JOSD1
| 2 3
BRD4 increases the amount of JOSD1.
| 2
BRD4 increases the amount of JOSD1. 2 / 2
| 2

reach
"Taken together, these evidences illustrate that BRD4, as an epigenetic modulator, enhances the expression of JOSD1 by facilitating its transcription activation."

reach
"Besides, we found that knockdown of BRD4 by shRNA, resembling the effect of JQ1, inhibited the expression of JOSD1 (Fig. 2e, f), while BRD4 overexpression significantly upregulated JOSD1 in HNSCC cells (Fig. 2g, h), suggesting that BRD4 affected JOSD1 expression at the transcriptional level."
BRD4 activates JOSD1.
| 2
BRD4 activates JOSD1. 2 / 2
| 2

eidos
"BRD4 inhibition downregulates JOSD1 in HNSCC ."

eidos
"Taken together , these evidences illustrate that BRD4 , as an epigenetic modulator , enhances the expression of JOSD1 by facilitating its transcription activation ."
BRD4 decreases the amount of JOSD1.
| 1
BRD4 decreases the amount of JOSD1. 1 / 1
| 1

reach
"Besides, we found that knockdown of BRD4 by shRNA, resembling the effect of JQ1, inhibited the expression of JOSD1 (Fig. 2e, f), while BRD4 overexpression significantly upregulated JOSD1 in HNSCC cells (Fig. 2g, h), suggesting that BRD4 affected JOSD1 expression at the transcriptional level."
5 |

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available
UBC affects JOSD1
4 |
4 |

No evidence text available

No evidence text available

No evidence text available

No evidence text available

reach
"Furthermore, we found the high expression of Ki67 in JOSD1-depleted xenografts, indicating that JOSD1 could accelerate tumor proliferation in HNSCC."

reach
"Furthermore, JOSD1 silencing could inhibit proliferation and enhance chemosensitivity of HNSCC cells in vitro and in vivo."

reach
"JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4."

reach
"Furthermore, we found the high expression of Ki67 in JOSD1-depleted xenografts, indicating that JOSD1 could accelerate tumor proliferation in HNSCC."
JOSD1 affects UBC
4 |
4 |

No evidence text available

No evidence text available

No evidence text available

No evidence text available
JOSD1 affects MCL1
| 2 2
JOSD1 binds MCL1.
| 1 2
| 1 2

sparser
"Further research showed that curcumol-induced Mcl-1 Ser159 phosphorylation is required to disrupt the interaction between deubiquitinase JOSD1 and Mcl-1 and eventually induce Mcl-1 ubiquitination and degradation."

sparser
"TRAF4 knockout inhibited the phosphorylation of Akt and upregulated GSK3β activity, resulting in increased myeloid cell leukemia-1 (MCL-1) S159 phosphorylation, which disrupted the interaction of MCL-1 with Josephin domain containing 1 (JOSD1), and ultimately induced MCL-1 ubiquitination and degradation."

reach
"Further research showed that curcumol-induced Mcl-1 Ser159 phosphorylation is required to disrupt the interaction between deubiquitinase JOSD1 and Mcl-1 and eventually induce Mcl-1 ubiquitination and degradation."
JOSD1 activates MCL1.
| 1
JOSD1 activates MCL1. 1 / 1
| 1

reach
"JOSD1 overexpression caused chemoresistance in gynaecological cancer by upregulating the MCL1 protein."
JOSD1 affects HNSCC
| 4
JOSD1 activates HNSCC.
| 3
JOSD1 activates HNSCC. 3 / 3
| 3

reach
"Furthermore, we found the high expression of Ki67 in JOSD1-depleted xenografts, indicating that JOSD1 could accelerate tumor proliferation in HNSCC."

reach
"Compared with sensitive specimens, JOSD1 expression was dramatically increased in chemoresistant tissues (Fig. 1d), indicating a potential role of JOSD1 in HNSCC chemoresistance."

reach
"In summary, these data demonstrate that JOSD1 upregulation in HNSCC positively correlated with poor prognosis of patients, uncovering the clinical prognostic significance of JOSD1."
JOSD1 inhibits HNSCC.
| 1
JOSD1 inhibits HNSCC. 1 / 1
| 1

reach
"Furthermore, we found the high expression of Ki67 in JOSD1-depleted xenografts, indicating that JOSD1 could accelerate tumor proliferation in HNSCC."
CREB1 affects JOSD1
4 |
CREB1 decreases the amount of JOSD1. 4 / 4
4 |

No evidence text available

No evidence text available

No evidence text available

No evidence text available
3 |
Cyclosporin A increases the amount of JOSD1. 3 / 3
3 |

No evidence text available

No evidence text available

No evidence text available
SOCS1 affects JOSD1
1 | 1 1
1 | 1 1

sparser
"JOSD1 physically interacts with SOCS1, which is an essential negative regulator of many cytokines signaling, and enhances SOCS1 stability by deubiquitinating K48-linked polyubiquitination of SOCS1."

No evidence text available

reach
"JOSD1 physically interacts with SOCS1, which is an essential negative regulator of many cytokines signaling, and enhances SOCS1 stability by deubiquitinating K48 linked polyubiquitination of SOCS1."
MCL1 affects JOSD1
| 1 2
| 1 2

sparser
"Further research showed that curcumol-induced Mcl-1 Ser159 phosphorylation is required to disrupt the interaction between deubiquitinase JOSD1 and Mcl-1 and eventually induce Mcl-1 ubiquitination and degradation."

sparser
"TRAF4 knockout inhibited the phosphorylation of Akt and upregulated GSK3β activity, resulting in increased myeloid cell leukemia-1 (MCL-1) S159 phosphorylation, which disrupted the interaction of MCL-1 with Josephin domain containing 1 (JOSD1), and ultimately induced MCL-1 ubiquitination and degradation."

reach
"Further research showed that curcumol-induced Mcl-1 Ser159 phosphorylation is required to disrupt the interaction between deubiquitinase JOSD1 and Mcl-1 and eventually induce Mcl-1 ubiquitination and degradation."
JOSD1 affects tumor growth
| 3
JOSD1 activates tumor growth. 3 / 3
| 3

eidos
"JOSD1 knockdown impedes tumor growth and increases chemosensitivity of HNSCC cells in vivo ."

eidos
"Additionally , JOSD1 suppression inhibited the tumor growth and improved chemosensitivity in vivo ."

eidos
"In our study , JOSD1 knockdown could inhibit the growth and colony formation of TSCCA and SCC25 cells , and suppress the tumor growth in vivo ."
| 3
| 2

reach
"Using siRNA-mediated JOSD1 knockdown, we confirmed that the loss of JOSD1 could markedly increase the apoptosis of gynecological cancer cells ."

reach
"Moreover, with the treatment of CDDP, JOSD1 knockdown could increase expression of apoptosis-related proteins and promote cell apoptosis rate."
| 1

reach
"JOSD1 depletion led to severe apoptosis in gynaecological cancer cells both in vivo and in vitro."
Cisplatin affects JOSD1
1 | 1
Cisplatin increases the amount of JOSD1.
1 |
Cisplatin increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Cisplatin activates JOSD1.
| 1
| 1

reach
"The results of MTT assay showed that the IC50 value of CDDP was dramatically reduced in the HNSCC cells expressing JOSD1 shRNAs, indicating that JOSD1 knockdown could sensitize HNSCC cells to CDDP (Fig. 4c)."
Bisphenol A affects JOSD1
2 |
Bisphenol A increases the amount of JOSD1. 2 / 2
2 |

No evidence text available

No evidence text available
TRIM27 affects JOSD1
2 |
2 |

No evidence text available

No evidence text available
SREBF1 affects JOSD1
2 |
SREBF1 decreases the amount of JOSD1. 2 / 2
2 |

No evidence text available

No evidence text available
PITX2 affects JOSD1
2 |
PITX2 decreases the amount of JOSD1. 2 / 2
2 |

No evidence text available

No evidence text available
JOSD1 is modified
| 2
JOSD1 is ubiquitinated. 2 / 2
| 2

sparser
"The ubiquitination of JosD1 triggers its localization to the membrane from the cytoskeletal fraction [ xref ]."

sparser
"Notably, JOSD1’s ubiquitination can regulate its catalytic activity, but this modification is not necessary for JOSD2 to exert its DUB function."
NHLH1 affects JOSD1
2 |
NHLH1 decreases the amount of JOSD1. 2 / 2
2 |

No evidence text available

No evidence text available
LEF1 affects JOSD1
2 |
LEF1 decreases the amount of JOSD1. 2 / 2
2 |

No evidence text available

No evidence text available
| 1
| 1

reach
"Indeed, time-lapse imaging revealed that JosD1 enhances membrane dynamics and cell motility."
JOSD1 affects cell growth
| 1 1
| 1 1

eidos
"Under the regulation of BRD4 , JOSD1 is a key driver of cell growth and chemoresistance in vitro and in vivo ."

reach
"Under the regulation of BRD4, JOSD1 is a key driver of cell growth and chemoresistance in vitro and in vivo."
JOSD1 affects TRIM27
2 |
2 |

No evidence text available

No evidence text available
JOSD1 affects EIF3F
2 |
2 |

No evidence text available

No evidence text available
Zinc atom affects JOSD1
1 |
Zinc atom increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Valproic acid increases the amount of JOSD1. 1 / 1
1 |

No evidence text available

No evidence text available
1 |
Tetrachloroethene increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Sunitinib affects JOSD1
1 |
Sunitinib increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Sulindac affects JOSD1
1 |
Sulindac decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available

eidos
"We found that NF-kappaB activation through each of these agents elicited a significant increase in APOBEC3B gene expression with less robust activation of APOBEC3C and no effect on JOSD1 ."
1 |
Pirinixic acid increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Paracetamol affects JOSD1
1 |
Paracetamol increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Pantogab affects JOSD1
1 |
Pantogab increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Nickel atom affects JOSD1
1 |
Nickel atom increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Nefazodone affects JOSD1
1 |
Nefazodone increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Methyltestosterone decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Methyl methanesulfonate increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Leflunomide affects JOSD1
1 |
Leflunomide increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Jinfukang affects JOSD1
1 |
Jinfukang increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Indometacin affects JOSD1
1 |
Indometacin increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-92b-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-92a-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-7847-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-769-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6864-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6849-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6771-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6746-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-6500-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Hsa-miR-650 affects JOSD1
1 |
Hsa-miR-650 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4802-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4796-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4786-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4524b-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4443 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-4293 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-3978 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-3688-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-3672 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-3614-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-3612 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-32-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-30e-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-30d-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-30c-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-30b-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-30a-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-26b-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-2392 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-186-5p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-1827 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-1324 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Hsa-miR-107 affects JOSD1
1 |
Hsa-miR-107 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Hsa-miR-103a-3p decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Flutamide affects JOSD1
1 |
Flutamide increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Finasteride affects JOSD1
1 |
Finasteride increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Facilitating transcription activation affects JOSD1
| 1
Facilitating transcription activation activates JOSD1. 1 / 1
| 1

eidos
"Taken together , these evidences illustrate that BRD4 , as an epigenetic modulator , enhances the expression of JOSD1 by facilitating its transcription activation ."
Epigenetic regulator BRD4 affects JOSD1
| 1
Epigenetic regulator BRD4 activates JOSD1. 1 / 1
| 1

eidos
"The epigenetic regulator BRD4 contributed to the upregulation of JOSD1 in HNSCC ."
Diuron affects JOSD1
1 |
Diuron increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Dibutyl phthalate increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Beta-naphthoflavone increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Benzene affects JOSD1
1 |
Benzene increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Administration JQ1 cells affects JOSD1
| 1
Administration JQ1 cells inhibits JOSD1. 1 / 1
| 1

eidos
"The results showed that the administration of JQ1 to HNSCC cells strikingly downregulated JOSD1 in mRNA and protein level ( Fig. 2c , d ) ."
Abrine affects JOSD1
1 |
Abrine increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
Zoledronic Acid increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
USP28 affects JOSD1
1 |
1 |

No evidence text available
USP21c affects JOSD1
| 1
USP21c activates JOSD1. 1 / 1
| 1

reach
"In addition, USP21c has been shown to cause complete removal of ubiquitin chains from not only itself, but also JOSD1 (XREF_FIG b)."
USP21 affects JOSD1
1 |
1 |

No evidence text available
USP15 affects JOSD1
1 |
1 |

No evidence text available
TRIM63 affects JOSD1
1 |
1 |

No evidence text available
TRIM54 affects JOSD1
1 |
1 |

No evidence text available
TRIM23 affects JOSD1
1 |
1 |

No evidence text available
TRAF1 affects JOSD1
1 |
1 |

No evidence text available
TIMM8A affects JOSD1
1 |
1 |

No evidence text available
TCF3 affects JOSD1
1 |
TCF3 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Sesame Oil affects JOSD1
1 |
Sesame Oil increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
STUB1 affects JOSD1
1 |
1 |

No evidence text available
SP1 affects JOSD1
1 |
SP1 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
POU6F1 affects JOSD1
1 |
POU6F1 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
PJA1 affects JOSD1
1 |
1 |

No evidence text available
PCI 5002 affects JOSD1
1 |
PCI 5002 increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
PAX2 affects JOSD1
1 |
PAX2 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
NOTCH2NLA affects JOSD1
1 |

No evidence text available
NFE2L2 affects JOSD1
1 |
NFE2L2 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
MYC affects JOSD1
1 |
MYC decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
MID2 affects JOSD1
1 |
1 |

No evidence text available
MAFG affects JOSD1
1 |
MAFG decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
LNX1 affects JOSD1
1 |
1 |

No evidence text available
LMO2 affects JOSD1
1 |
LMO2 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
KRTAP9-2 affects JOSD1
1 |

No evidence text available
KRTAP5-9 affects JOSD1
1 |

No evidence text available
KRTAP10-8 affects JOSD1
1 |

No evidence text available
KRTAP10-4 affects JOSD1
1 |

No evidence text available
KRTAP10-3 affects JOSD1
1 |

No evidence text available
KRT40 affects JOSD1
1 |
1 |

No evidence text available
KRT31 affects JOSD1
1 |
1 |

No evidence text available
K 7174 affects JOSD1
1 |
K 7174 increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
JQ1 affects JOSD1
| 1
JQ1 inhibits JOSD1. 1 / 1
| 1

reach
"The results showed that the administration of JQ1 to HNSCC cells strikingly downregulated JOSD1 in mRNA and protein level (Fig. 2c, d)."
JOSD1 affects tumor cell
| 1
JOSD1 activates tumor cell. 1 / 1
| 1

eidos
"Furthermore , we found that JOSD1 knockdown suppressed tumor cell proliferation and metastasis , whereas overexpression of JOSD1 led to opposite phenotypes ."
JOSD1 affects tumor cell invasion
| 1
JOSD1 activates tumor cell invasion. 1 / 1
| 1

eidos
"Indeed , JOSD1 promoted tumor cell invasion as well as metastasis on the dependence of Snail ."
JOSD1 affects signal cascade
| 1
JOSD1 inhibits signal cascade. 1 / 1
| 1

eidos
"JOSD1 inhibits the IFN signal cascade via deubiquitinating and stabilizing SOCS1 [ 92 ] ."
JOSD1 affects pathway
| 1
JOSD1 inhibits pathway. 1 / 1
| 1

sparser
"JOSD1 inhibits the mitochondrial apoptosis pathway and exerts anti-apoptosis effects and results in chemo-resistance in gynaecological cancer by stabilizing MCL1."
JOSD1 affects metastasis dependence Snail
| 1
JOSD1 activates metastasis dependence Snail. 1 / 1
| 1

eidos
"Indeed , JOSD1 promoted tumor cell invasion as well as metastasis on the dependence of Snail ."
| 1
| 1

reach
"The ubiquitination of JosD1 triggers its localization to the membrane from the cytoskeletal fraction [38]."
JOSD1 affects growth colony TSCCA SCC25 cells
| 1
JOSD1 activates growth colony TSCCA SCC25 cells. 1 / 1
| 1

eidos
"In our study , JOSD1 knockdown could inhibit the growth and colony formation of TSCCA and SCC25 cells , and suppress the tumor growth in vivo ."

reach
"JOSD1 has been identified to negatively regulate IFN-I-induced signaling and the antiviral response by deubiquitinating the K48-linked polyubiquitination of SOCS1, which is an essential negative regulator of many cytokine signaling pathways (120)."
JOSD1 affects cisplatin-induced apoptosis HNSCC cells
| 1
JOSD1 inhibits cisplatin-induced apoptosis HNSCC cells. 1 / 1
| 1

eidos
"Moreover , JOSD1 depletion dramatically impaired cell proliferation and colony formation , and promoted cisplatin-induced apoptosis of HNSCC cells in vitro ."
JOSD1 affects chemosensitivity HNSCC cells
| 1
JOSD1 inhibits chemosensitivity HNSCC cells. 1 / 1
| 1

eidos
"JOSD1 knockdown impedes tumor growth and increases chemosensitivity of HNSCC cells in vivo ."
JOSD1 affects chemoresistance
| 1
JOSD1 activates chemoresistance. 1 / 1
| 1

eidos
"Under the regulation of BRD4 , JOSD1 is a key driver of cell growth and chemoresistance in vitro and in vivo ."
JOSD1 affects chemoresistance head neck squamous cell carcinoma epigenetic regulation enzymes
| 1
JOSD1 activates chemoresistance head neck squamous cell carcinoma epigenetic regulation enzymes. 1 / 1
| 1

eidos
"JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4 Background Deubiquitinating enzymes ( DUBs ) play critical roles in various cancers by modulating functional proteins post-translationally ."
JOSD1 affects chemoresistance head neck squamous cell carcinoma epigenetic regulation BRD4
| 1
JOSD1 activates chemoresistance head neck squamous cell carcinoma epigenetic regulation BRD4. 1 / 1
| 1

eidos
"JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4 ."
JOSD1 affects cell apoptosis
| 1
JOSD1 inhibits cell apoptosis. 1 / 1
| 1

eidos
"Moreover , with the treatment of CDDP , JOSD1 knockdown could increase expression of apoptosis-related proteins and promote cell apoptosis rate ."
JOSD1 affects capacity colony
| 1
JOSD1 activates capacity colony. 1 / 1
| 1

eidos
"Moreover , reduced level of JOSD1 impaired the capacity of colony formation in both TSCCA and SCC25 cells ( Fig. 5b ) ."
JOSD1 affects apoptosis-related proteins
| 1
JOSD1 inhibits apoptosis-related proteins. 1 / 1
| 1

eidos
"Moreover , with the treatment of CDDP , JOSD1 knockdown could increase expression of apoptosis-related proteins and promote cell apoptosis rate ."
JOSD1 affects apoptosis HNSCC cells treated CDDP flow cytometry
| 1
JOSD1 inhibits apoptosis HNSCC cells treated CDDP flow cytometry. 1 / 1
| 1

eidos
"Meanwhile , we found that depletion of JOSD1 led to a significant increase of apoptosis rate of HNSCC cells treated with CDDP by using flow cytometry ( Fig. 4d ) ."
JOSD1 affects acquired chemoresistance
| 1
JOSD1 activates acquired chemoresistance. 1 / 1
| 1

eidos
"In gynaecological cancer , JOSD1 promotes acquired chemoresistance by stabilizing MCL1 [ 14 ] ."
JOSD1 affects USP28
1 |
1 |

No evidence text available
JOSD1 affects USP21
1 |
1 |

No evidence text available
JOSD1 affects USP15
1 |
1 |

No evidence text available
JOSD1 affects TRIM63
1 |
1 |

No evidence text available
JOSD1 affects TRIM54
1 |
1 |

No evidence text available
JOSD1 affects TRIM23
1 |
1 |

No evidence text available
JOSD1 affects TRAF1
1 |
1 |

No evidence text available
JOSD1 affects TIMM8A
1 |
1 |

No evidence text available

reach
"JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4."
JOSD1 affects STUB1
1 |
1 |

No evidence text available
JOSD1 affects PJA1
1 |
1 |

No evidence text available

eidos
"Furthermore , we found that JOSD1 knockdown suppressed tumor cell proliferation and metastasis , whereas overexpression of JOSD1 led to opposite phenotypes ."
JOSD1 affects NOTCH2NLA
1 |

No evidence text available
JOSD1 affects MID2
1 |
1 |

No evidence text available
JOSD1 affects LNX1
1 |
1 |

No evidence text available
JOSD1 affects KRTAP9-2
1 |

No evidence text available
JOSD1 affects KRTAP5-9
1 |

No evidence text available
JOSD1 affects KRTAP10-8
1 |

No evidence text available
JOSD1 affects KRTAP10-4
1 |

No evidence text available
JOSD1 affects KRTAP10-3
1 |

No evidence text available
JOSD1 affects KRT40
1 |
1 |

No evidence text available
JOSD1 affects KRT31
1 |
1 |

No evidence text available
JOSD1 affects JOSD1
| 1
JOSD1 activates JOSD1. 1 / 1
| 1

reach
"Compared with sensitive specimens, JOSD1 expression was dramatically increased in chemoresistant tissues (Fig. 1d), indicating a potential role of JOSD1 in HNSCC chemoresistance."
JOSD1 affects JAK2-V617F
| 1
JOSD1 binds JAK2-V617F. 1 / 1
| 1

reach
"JOSD1 interacts with and stabilizes JAK2-V617F, and inactivation of the DUB leads to JAK2-V617F protein degradation by increasing its ubiquitination levels, thereby shortening its protein half-life."
JOSD1 affects HNSCC cell
| 1
JOSD1 activates HNSCC cell. 1 / 1
| 1

eidos
"JOSD1 depletion inhibits HNSCC cell proliferation in vitro ."
JOSD1 affects ELAVL1
1 |
1 |

No evidence text available
JOSD1 affects CDDP treating HNSCC
| 1
JOSD1 inhibits CDDP treating HNSCC. 1 / 1
| 1

eidos
"Meanwhile , JOSD1 silencing combined with CDDP treatment extremely enhanced the positive staining of cleaved Caspase-3 compared with the other three groups ( Fig. 6c ) , which indicated that JOSD1 knockdown could improve the effect of CDDP for treating HNSCC in vivo ."
JOSD1 affects CALM1
1 |
1 |

No evidence text available
JAK2-V617F affects JOSD1
| 1
JOSD1 binds JAK2-V617F. 1 / 1
| 1

reach
"JOSD1 interacts with and stabilizes JAK2-V617F, and inactivation of the DUB leads to JAK2-V617F protein degradation by increasing its ubiquitination levels, thereby shortening its protein half-life."
Ischemia affects JOSD1
1 |
Ischemia increases the amount of JOSD1. 1 / 1
1 |

"Table 1 - Lists of differentially expressed genes during ischemia and reperfusion identified with SAM, as described in the text"
ICG 001 affects JOSD1
1 |
ICG 001 increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
Grape Seed Proanthocyanidins decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
GFI1 affects JOSD1
1 |
GFI1 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
ELAVL1 affects JOSD1
1 |
1 |

No evidence text available
E4F1 affects JOSD1
1 |
E4F1 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
D-glucopyranose increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
CALM1 affects JOSD1
1 |
1 |

No evidence text available
BRD4 shRNA resembling JQ1 affects JOSD1
| 1
BRD4 shRNA resembling JQ1 activates JOSD1. 1 / 1
| 1

eidos
"Besides , we found that knockdown of BRD4 by shRNA , resembling the effect of JQ1 , inhibited the expression of JOSD1 ( Fig. 2e , f ) , while BRD4 overexpression significantly upregulated JOSD1 in HNSCC cells ( Fig. 2g , h ) , suggesting that BRD4 affected JOSD1 expression at the transcriptional level ."
BRD4 overexpression affects JOSD1
| 1
BRD4 overexpression activates JOSD1. 1 / 1
| 1

eidos
"Besides , we found that knockdown of BRD4 by shRNA , resembling the effect of JQ1 , inhibited the expression of JOSD1 ( Fig. 2e , f ) , while BRD4 overexpression significantly upregulated JOSD1 in HNSCC cells ( Fig. 2g , h ) , suggesting that BRD4 affected JOSD1 expression at the transcriptional level ."
Air Pollutants, Occupational increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
ATF6 affects JOSD1
1 |
ATF6 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
ATF4 affects JOSD1
1 |
ATF4 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
ATF2 affects JOSD1
1 |
ATF2 decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
ARNT affects JOSD1
1 |
ARNT decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available

reach
"The results of MTT assay showed that the IC50 value of CDDP was dramatically reduced in the HNSCC cells expressing JOSD1 shRNAs, indicating that JOSD1 knockdown could sensitize HNSCC cells to CDDP (Fig. 4c)."
1 |
2-butoxyethanol increases the amount of JOSD1. 1 / 1
1 |

No evidence text available
17alpha-ethynylestradiol decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |
(+)-catechin decreases the amount of JOSD1. 1 / 1
1 |

No evidence text available
1 |

No evidence text available